DK1847607T3 - Antistoffer mod p51-protein - Google Patents

Antistoffer mod p51-protein

Info

Publication number
DK1847607T3
DK1847607T3 DK07013470.5T DK07013470T DK1847607T3 DK 1847607 T3 DK1847607 T3 DK 1847607T3 DK 07013470 T DK07013470 T DK 07013470T DK 1847607 T3 DK1847607 T3 DK 1847607T3
Authority
DK
Denmark
Prior art keywords
protein
antibodies
recombinant
fragment
antibody
Prior art date
Application number
DK07013470.5T
Other languages
English (en)
Inventor
Yoji Ikawa
Shuntaro Ikawa
Masuo Obinata
Original Assignee
Otsuka Pharma Co Ltd
Yoji Ikawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Yoji Ikawa filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1847607T3 publication Critical patent/DK1847607T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK07013470.5T 1998-03-27 1999-03-24 Antistoffer mod p51-protein DK1847607T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10046798 1998-03-27
EP99910698A EP1065270B1 (en) 1998-03-27 1999-03-24 HUMAN p51 GENES AND GENE PRODUCTS THEREOF

Publications (1)

Publication Number Publication Date
DK1847607T3 true DK1847607T3 (da) 2011-07-18

Family

ID=14274724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07013470.5T DK1847607T3 (da) 1998-03-27 1999-03-24 Antistoffer mod p51-protein

Country Status (13)

Country Link
US (4) US7132276B1 (da)
EP (2) EP1847607B1 (da)
JP (1) JP4336926B2 (da)
CN (1) CN100340665C (da)
AT (2) ATE366810T1 (da)
CA (1) CA2324649C (da)
CY (1) CY1111763T1 (da)
DE (1) DE69936513D1 (da)
DK (1) DK1847607T3 (da)
ES (1) ES2366234T3 (da)
HK (1) HK1034288A1 (da)
PT (1) PT1847607E (da)
WO (1) WO1999050412A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7038028B1 (en) 1999-06-29 2006-05-02 Toshiyuki Sakai Gene encoding promoter domain of tumor suppressor gene P51 and use thereof
TW200532523A (en) * 2004-02-27 2005-10-01 Aureon Biosciences Corp Methods and systems for predicting occurrence of an event
CN102181571A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定猪遗传稳定性相关基因的专用引物及其应用
CN102181570A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定鼠遗传稳定性相关基因的专用引物及其应用
CN104212879B (zh) * 2013-06-05 2016-09-21 上海派森诺生物科技股份有限公司 一种基于磁珠富集法高通量开发基因组ssr标记的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744455B1 (fr) * 1996-02-02 1998-04-24 Sanofi Sa Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
AU7478098A (en) 1997-05-12 1998-12-08 Dana-Farber Cancer Institute Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
US7294459B1 (en) * 1997-10-15 2007-11-13 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
WO1999019357A2 (en) * 1997-10-15 1999-04-22 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
ATE345387T1 (de) 1998-03-18 2006-12-15 Corixa Corp Verbindungen und verfahren für therapie und diagnose von lungenkrebs
US6476206B1 (en) 1998-03-27 2002-11-05 The Johns Hopkins University p40 protein acts as an oncogene
DE19822985C1 (de) 1998-05-25 2000-01-13 Fraunhofer Ges Forschung Tumorsuppressorgene der p53-Familie

Also Published As

Publication number Publication date
CY1111763T1 (el) 2015-10-07
CA2324649A1 (en) 1999-10-07
US20100285499A1 (en) 2010-11-11
EP1065270A1 (en) 2001-01-03
CN1295615A (zh) 2001-05-16
US20060115852A1 (en) 2006-06-01
EP1065270B1 (en) 2007-07-11
EP1065270A4 (en) 2004-12-29
US7553933B2 (en) 2009-06-30
DE69936513D1 (de) 2007-08-23
EP1847607B1 (en) 2011-06-08
ES2366234T3 (es) 2011-10-18
ATE512162T1 (de) 2011-06-15
PT1847607E (pt) 2011-08-25
US7132276B1 (en) 2006-11-07
US20090142783A1 (en) 2009-06-04
ATE366810T1 (de) 2007-08-15
HK1034288A1 (en) 2001-10-19
EP1847607A1 (en) 2007-10-24
CN100340665C (zh) 2007-10-03
WO1999050412A1 (fr) 1999-10-07
US7964367B2 (en) 2011-06-21
US7754857B2 (en) 2010-07-13
CA2324649C (en) 2007-05-15
JP4336926B2 (ja) 2009-09-30

Similar Documents

Publication Publication Date Title
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE69535147D1 (de) Überexpression von säugetier- und virusproteinen
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
CY1111763T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
ATE339878T1 (de) Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
ATE378408T1 (de) Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
NO882380D0 (no) Fibfonektin-bindende protein, samt fremstilling derav.
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
ATE309351T1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
ATE309363T1 (de) Hybrid-toxine von bacillus thuringiensis
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK0779297T3 (da) Antigene peptider med glycinsubstitutioner
DK0959895T3 (da) Peptider modtagelige over for antistoffer mod peptidconsensussekvenser af C24-CFA/I proteinfamilien
DE69831584D1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
NZ606260A (en) Novel polypeptides involved in immune response
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
ATE492640T1 (de) Loslösendes protein 5 - ucp5
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.